# Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/brigatinib-versus-crizotinib-in-advanced-alk-inhibitor-naive-alk-positive-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | D. Ross Camidge,Hye Ryun Kim,Myung‐Ju Ahn,James Chih‐Hsin Yang,Ji‐Youn Han,Maximilian J. Hochmair,Ki Hyeong Lee,Angelo Delmonte,M.R. García Campelo,Dong‐Wan Kim,Frank Griesinger,Enriqueta Felip,Raffaele Califano,Alexander I. Spira,Scott Gettinger,Marcello Tiseo,Huamao Mark Lin,Neeraj Gupta,Michael J. Hanley,Quanhong Ni,Pingkuan Zhang,Sanjay Popat |
| Citations | 367 |
| DOI | 10.1200/jco.20.00505 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.20.00505 |
| OpenAlex ID | https://openalex.org/W3048441995 |
| PMID | 32780660 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Myung‐Ju Ahn](https://scholariq.org/researchers/myung-ju-ahn/)
- [Frank Griesinger](https://scholariq.org/researchers/frank-griesinger/)
- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)
- [Marcello Tiseo](https://scholariq.org/researchers/marcello-tiseo/)
- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.